S. W. Lee Et Al. , "Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.," Alimentary pharmacology & therapeutics , vol.59, no.1, pp.80-88, 2024
Lee, S. W. Et Al. 2024. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.. Alimentary pharmacology & therapeutics , vol.59, no.1 , 80-88.
Lee, S. W., Huang, D. Q., Bettencourt, R., Ajmera, V., Tincopa, M., Noureddin, N., ... Amangurbanova, M.(2024). Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.. Alimentary pharmacology & therapeutics , vol.59, no.1, 80-88.
Lee, Sung Et Al. "Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.," Alimentary pharmacology & therapeutics , vol.59, no.1, 80-88, 2024
Lee, Sung W. Et Al. "Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.." Alimentary pharmacology & therapeutics , vol.59, no.1, pp.80-88, 2024
Lee, S. W. Et Al. (2024) . "Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.." Alimentary pharmacology & therapeutics , vol.59, no.1, pp.80-88.
@article{article, author={Sung Won Lee Et Al. }, title={Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.}, journal={Alimentary pharmacology & therapeutics}, year=2024, pages={80-88} }